Amid pandemic, hybrid mode of working has been accepted across industry. How companies are making sure they don't miss on coordination and what are challenges in keeping productivity high. Experts discuss on Day 2 of BT MindRush 2021

There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine

The number of people who have recuperated from the disease surged to 99,06,387, pushing the national recovery rate to 96.12 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent

China has ramped up disinfection and virus testing on frozen food after it found coronavirus on imported products and packaging

People coming under the priority group category, that is, health workers, frontline workers, people above the age of 50 and those under 50 but suffering from co-morbid conditions,  can register on ahmedabadcity.gov.in

Around 2,360 participants have been trained during the national-level training. The state-level training has been completed in all states/UTs and 7,000 district level trainees got hands-on experience on vaccine handling and distribution

The Phase 3 clinical trials of Covaxin began in mid-November with a target of 26,000 volunteers. Bharat Biotech's is the first and only Phase 3 efficacy study for a vaccine developed in the country

Innovations such as mixed-model mobility solutions where the same assets are used for multiple services over the week can help fleet operators drive up asset utilisation, drive down unit prices for consumers and deliver better economics

Two vaccine candidates stumbled on Friday in the race among researchers to combat Covid-19, even as the Pfizer jab nears approval in the US

The vaccine developer said on Saturday that the Covaxin clinical trials are based on a 2-dose routine, the two doses are administered 28 days apart and vaccine efficacy will be determined 14 days post the second dose

The top two players - Zerodha and Upstox - now have over 26 lakh and nearly 14 lakh active clients, respectively on the NSE as of October-end, while ICICI Securities has 12.15 lakh clients

Reliance confirms buying stake in lingerie retailer ZivameReliance Industries (RIL), in an exchange filing, confirmed that it has acquired a minority stake in Actoserba Active Wholesale, which owns and operates online lingerie store Zivame. The transaction was concluded in the first half year ended September 30, 2020.COVID-19: RT-PCR tests in Delhi to cost Rs 800The Arvind Kejriwal government on Monday ordered all private laboratories to reduce the price of RT-PCR tests in the national cap...

New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy band

Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh

Two other cars -- Hyundai Grand i10 Nios and Kia Seltos were also tested and though they fared better than the S-Presso, none of them managed to get a very high rating

They reported the design of a 'heat-tolerant' COVID-19 vaccine candidate and a rapid method to identify specific regions on the HIV envelopeprotein that are targeted by antibodies, which can help design effective vaccines

Scientists have developed a vaccine candidate for COVID-19 that produces high levels of antibodies and better immune response in animals. J&J vaccine trials have resumed in Brazil and Mexico has received coronavirus vaccine from CanSino Biologics for late-stage trials

Coronavirus vaccine update: Staff from eight of the 25 Moscow clinics where the trials are taking place said that the vaccination of new participants in the Phase 3 of trials have been temporarily paused

Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy

Coronavirus vaccine update: Biopharma company Epygen Biotech with operations in Mumbai and Dubai is planning to launch an affordable COVID-19 vaccine with an aim to roll out 500 million doses within six months